Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07399028 · ClinicalTrials.gov registry record · NA
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
A NA study of Skin Laxity and Photo-aged Skin, sponsored by Galderma R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07399028: Recruiting NA study of Skin Laxity and Photo-aged Skin, sponsored by Galderma R&D.
NCT07399028 is a NA study of Skin Laxity and Photo-aged Skin that is actively recruiting participants, run by Galderma R&D. The registered enrollment target is 25 participants, below the 188-participant average among 10 other Skin Laxity trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07399028, a NA study of Skin Laxity and Photo-aged Skin, is actively recruiting participants, sponsored by Galderma R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Adult subjects with moderate-to-severe cheek wrinkles will be treated with Sculptra for correction of fine lines and wrinkles in the cheek area.
Primary Outcome
Images taken with VISIA imaging system and an imaging system using tomography technology at baseline and post-baseline timepoints will be compared to assess structural changes in cheeks.
Conditions Studied
Interventions
- DEVICE Sculptra®
Study Locations (1)
New York
- Luxurgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-10-21 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT07399028 shows while recruiting
NCT07399028 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 188-participant average among 10 other Skin Laxity trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Sculptra® is the first listed.
NCT07399028 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07399028 about?
NCT07399028 is a clinical study titled "A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging". Adult subjects with moderate-to-severe cheek wrinkles will be treated with Sculptra for correction of fine lines and wrinkles in the cheek area.
What is the current status of trial NCT07399028?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-10-21. Estimated completion is 2026-09.
What conditions does trial NCT07399028 study?
This clinical trial studies the following conditions: Skin Laxity, Photo-aged Skin, Volume Deficiency in the Mid-Face.
What interventions are being tested in trial NCT07399028?
The interventions under investigation include: Sculptra® (DEVICE).
Who is sponsoring clinical trial NCT07399028?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07399028 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07399028's enrollment target sits among peer trials
25 8th of 10 higher than 3 of 10 other Skin Laxity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Laxity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Feasibility Study: Heavy Water Tissue Labeling Protocol
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI